Xtant Medical (NYSE MKT: XTNT) is an international medical product supply company with a mission to provide quality regenerative surgical products for the treatment of degenerative, traumatic and deformity conditions for orthopedic and neurological applications. In November 2016, the company was granted two paramount FDA approvals: one for its Irix-C cervical cage, and another for its Xsert Lumbar Expandable Interbody System. The company estimates the U.S market for lumbar interbody devices at $1.3 million and growing, while the worldwide market for Demineralized Bone Matrix (DBM) is estimated at $485 million. Irix-C is currently available and the initial product release for Xsert is anticipated in mid-2017.
To learn more, visit www.xtantmedical.com
About Xtant Medical Holdings
Xtant Medical Holdings, Inc. (NYSE MKT:XTNT) develops, manufactures and markets class-leading regenerative medicine products and medical devices for domestic and international markets. Xtant products serve the specialized needs of orthopedic and neurological surgeons, including orthobiologics for the promotion of bone healing, implants and instrumentation for the treatment of spinal disease, tissue grafts for the treatment of orthopedic disorders, and biologics to promote healing following cranial, and foot and ankle surgeries. With core competencies in both biologic and non-biologic surgical technologies, Xtant can leverage its resources to successfully compete in global neurological and orthopedic surgery markets.
NetworkNewsBreak (NNB) provides a rapid summary of corporate news that caught the attention of NetworkNewsWire (NNW). NNB keeps you up-to-date on active US Public Companies complementary to NNW’s broader scope as a provider of news aggregation and syndication, enhanced press release services and a full array of social communication solutions. As a multifaceted financial news and distribution company with an extensive team of journalists and writers, NNW is uniquely positioned to best serve private and public companies who need to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.
For more information, visit https://www.NetworkNewsWire.com.
Please see full disclaimers on the NetworkNewsWire website: http://nnw.fm/Disclaimer